- Prescribing Advice for GPs - https://www.prescriber.org.uk -

NICE Guidance - October 2010

The National Institute of Health and Clinical Excellence has published new guidance for the month of October 2010. This month there is one clinical guideline and one technology appraisal that impact upon primary care.

The nocturnal enuresis clinical guideline (QRG) provides evidence-based advice on the assessment, care and treatment of children and young people up to the age of 19 with bedwetting.

The technology appraisal (QRG) reviews the place for liraglutide (Victoza®) in the treatment of type 2 diabetes mellitus. It is recommended as an alternative to exenatide (Byetta®) in the following circumstances:

Action: Clinicians should be aware of these recommendations and implement any necessary changes to practice.